Coronavirus disease 2019 in chronic kidney disease

69Citations
Citations of this article
203Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The clinical spectrum of coronavirus disease 2019 (COVID-19) infection ranges from asymptomatic infection to severe pneumonia with respiratory failure and even death. More severe cases with higher mortality have been reported in older patients and in those with chronic illness such as hypertension, diabetes or cardiovascular diseases. In this regard, patients with chronic kidney disease (CKD) have a higher rate of all-type infections and cardiovascular disease than the general population. A markedly altered immune system and immunosuppressed state may predispose CKD patients to infectious complications. Likewise, they have a state of chronic systemic inflammation that may increase their morbidity and mortality. In this review we discuss the chronic immunologic changes observed in CKD patients, the risk of COVID-19 infections and the clinical implications for and specific COVID-19 therapy in CKD patients. Indeed, the risk for severe COVID-19 is 3-fold higher in CKD than in non-CKD patients; CKD is 12-fold more frequent in intensive care unit than in non-hospitalized COVID-19 patients, and this ratio is higher than for diabetes or cardiovascular disease; and acute COVID-19 mortality is 15-25% for haemodialysis patients even when not developing pneumonia.

References Powered by Scopus

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

35167Citations
N/AReaders
Get full text

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

19985Citations
N/AReaders
Get full text

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

8789Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Sustainable Development Goals relevant to kidney health: an update on progress

123Citations
N/AReaders
Get full text

Incidence and Outcomes of COVID-19 in People With CKD: A Systematic Review and Meta-analysis

92Citations
N/AReaders
Get full text

Anticipating the long-term cardiovascular effects of COVID-19

74Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

D’Marco, L., Puchades, M. J., Romero-Parra, M., Gimenez-Civera, E., Soler, M. J., Ortiz, A., & Gorriz, J. L. (2020). Coronavirus disease 2019 in chronic kidney disease. Clinical Kidney Journal, 13(3), 297–306. https://doi.org/10.1093/ckj/sfaa104

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 33

54%

Researcher 16

26%

Professor / Associate Prof. 8

13%

Lecturer / Post doc 4

7%

Readers' Discipline

Tooltip

Medicine and Dentistry 58

71%

Nursing and Health Professions 12

15%

Pharmacology, Toxicology and Pharmaceut... 6

7%

Biochemistry, Genetics and Molecular Bi... 6

7%

Article Metrics

Tooltip
Social Media
Shares, Likes & Comments: 1

Save time finding and organizing research with Mendeley

Sign up for free